中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation

文献类型:期刊论文

作者Dong, Jinyun1,2; Cheng, Xiang-Dong1,2; Zhang, Wei-Dong3; Qin, Jiang-Jiang1,2
刊名JOURNAL OF MEDICINAL CHEMISTRY
出版日期2021-07-08
卷号64
ISSN号0022-2623
DOI10.1021/acs.jmedchem.1c00629
通讯作者Qin, Jiang-Jiang(jqin@ucas.ac.cn)
英文摘要Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that regulates various biological processes, including proliferation, metastasis, angiogenesis, immune response, and chemoresistance. In normal cells, STAT3 is tightly regulated to maintain a transiently active state, while persistent STAT3 activation occurs frequently in cancers, associating with a poor prognosis and tumor progression. Targeting the STAT3 protein is a potentially promising therapeutic strategy for tumors. Although none of the STAT3 inhibitors has been marketed yet, a few of them have succeeded in entering clinical trials. This Review aims to systematically summarize the progress of the last 5 years in the discovery of directive STAT3 small-molecule inhibitors and degraders, focusing primarily on their structural features, design strategies, and bioactivities. We hope this Review will shed light on future drug design and inhibitor optimization to accelerate the discovery process of STAT3 inhibitors or degraders.
WOS关键词TRANSCRIPTION 3 STAT3 ; DNA-BINDING ACTIVITY ; SIGNAL TRANSDUCER ; INDOLEAMINE 2,3-DIOXYGENASE ; TARGETING STAT3 ; BIOLOGICAL EVALUATION ; TUMOR-GROWTH ; IN-VITRO ; DERIVATIVES ; ACTIVATION
资助项目Program of Zhejiang Provincial TCM Sci-tech Plan[2020ZZ005] ; Zhejiang Provincial Natural Science Foundation of China[LQ21B020003] ; Zhejiang Provincial Natural Science Foundation of China[LR21H280001] ; National Natural Science Foundation of China[81903842]
WOS研究方向Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000672729800003
出版者AMER CHEMICAL SOC
资助机构Program of Zhejiang Provincial TCM Sci-tech Plan ; Zhejiang Provincial Natural Science Foundation of China ; National Natural Science Foundation of China
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/123598]  
专题中国科学院合肥物质科学研究院
通讯作者Qin, Jiang-Jiang
作者单位1.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou 310022, Zhejiang, Peoples R China
2.Chinese Acad Sci, Inst Basic Med & Canc IBMC, Hangzhou 310018, Zhejiang, Peoples R China
3.Naval Med Univ, Sch Pharm, Shanghai 200433, Peoples R China
推荐引用方式
GB/T 7714
Dong, Jinyun,Cheng, Xiang-Dong,Zhang, Wei-Dong,et al. Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation[J]. JOURNAL OF MEDICINAL CHEMISTRY,2021,64.
APA Dong, Jinyun,Cheng, Xiang-Dong,Zhang, Wei-Dong,&Qin, Jiang-Jiang.(2021).Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation.JOURNAL OF MEDICINAL CHEMISTRY,64.
MLA Dong, Jinyun,et al."Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation".JOURNAL OF MEDICINAL CHEMISTRY 64(2021).

入库方式: OAI收割

来源:合肥物质科学研究院

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。